Misleading behavioural phenotype with adenylosuccinate lyase deficiency.

Practice guidelines for the molecular analysis of Prader-Willi and Angelman syndromes. BMC Med Genet (2010) 1.30

Molecular and Clinical Aspects of Angelman Syndrome. Mol Syndromol (2011) 1.27

Adenylosuccinate lyase deficiency. J Inherit Metab Dis (2014) 0.95

Metabolic disorders of purine metabolism affecting the nervous system. Handb Clin Neurol (2013) 0.93

Mental retardation and inborn errors of metabolism. J Inherit Metab Dis (2009) 0.87

Magnetic resonance imaging of the brain in adenylosuccinate lyase deficiency: a report of seven cases and a review of the literature. Eur J Pediatr (2011) 0.82

A test for ancient selective sweeps and an application to candidate sites in modern humans. Mol Biol Evol (2014) 0.81

Structural and biochemical characterization of human adenylosuccinate lyase (ADSL) and the R303C ADSL deficiency-associated mutation. Biochemistry (2012) 0.79

Testing for Ancient Selection Using Cross-population Allele Frequency Differentiation. Genetics (2015) 0.78

The molecular basis of cognitive deficits in pervasive developmental disorders. Learn Mem (2012) 0.77

Molecular characterization of the AdeI mutant of Chinese hamster ovary cells: a cellular model of adenylosuccinate lyase deficiency. Mol Genet Metab (2010) 0.77

Phenotype-genotype discordance in congenital malformations with communication disorders resembling trisomy 18 (Edwards syndrome). Am J Case Rep (2014) 0.75

Novel proton MR spectroscopy findings in adenylosuccinate lyase deficiency. J Magn Reson Imaging (2012) 0.75

Further Clinical Delineation of the MEF2C Haploinsufficiency Syndrome: Report on New Cases and Literature Review of Severe Neurodevelopmental Disorders Presenting with Seizures, Absent Speech, and Involuntary Movements. J Pediatr Genet (2017) 0.75

A mild form of adenylosuccinate lyase deficiency in absence of typical brain MRI features diagnosed by whole exome sequencing. Ital J Pediatr (2017) 0.75

Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A (2006) 2.86

Angelman syndrome: mimicking conditions and phenotypes. Am J Med Genet (2001) 2.00

An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids. Lancet (1984) 1.61

Adenylosuccinate lyase deficiency. Mol Genet Metab (2006) 1.20

Adenylosuccinase deficiency: an inborn error of purine nucleotide synthesis. Eur J Pediatr (1988) 1.08

Clinical, biochemical and molecular genetic correlations in adenylosuccinate lyase deficiency. Hum Mol Genet (2000) 1.03

Inborn errors of the purine nucleotide cycle: adenylosuccinase deficiency. J Inherit Metab Dis (1997) 0.99

Detection of 5'-phosphoribosyl-4-(N-succinylcarboxamide)-5-aminoimidazole in urine by use of the Bratton-Marshall reaction: identification of patients deficient in adenylosuccinate lyase activity. Anal Biochem (1986) 0.98

Lethal fetal and early neonatal presentation of adenylosuccinate lyase deficiency: observation of 6 patients in 4 families. J Pediatr (2007) 0.97

Social phenotypes in neurogenetic syndromes. Child Adolesc Psychiatr Clin N Am (2007) 0.96

Behavioral aspects of Angelman syndrome: a case control study. Am J Med Genet A (2005) 0.95

Residual adenylosuccinase activities in fibroblasts of adenylosuccinase-deficient children: parallel deficiency with adenylosuccinate and succinyl-AICAR in profoundly retarded patients and non-parallel deficiency in a mildly retarded girl. J Inherit Metab Dis (1993) 0.94

Adenylosuccinate lyase deficiency: from the clinics to molecular biology. Adv Exp Med Biol (2000) 0.87

Adenylosuccinase deficiency presenting with epilepsy in early infancy. J Inherit Metab Dis (1997) 0.86

Towards a suggestive facial dysmorphism in adenylosuccinate lyase deficiency? J Med Genet (2002) 0.83

Adenylosuccinase deficiency with neonatal onset severe epileptic seizures and sudden death. Neuropediatrics (1998) 0.83

Adenylosuccinase deficiency: an unusual cause of early-onset epilepsy associated with acquired microcephaly. Brain Dev (2000) 0.82

Adenylosuccinase deficiency: clinical and biochemical findings in 5 Czech patients. J Inherit Metab Dis (1997) 0.81

A behavioral neurogenetics approach to developmental disabilities: gene-brain-behavior associations. Curr Opin Neurol (1994) 0.80

Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet (2009) 5.84

Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol (2010) 4.03

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med (2011) 3.21

Allogeneic bone marrow transplantation in mevalonic aciduria. N Engl J Med (2007) 3.18

Mutations in the beta-tubulin gene TUBB2B result in asymmetrical polymicrogyria. Nat Genet (2009) 3.01

PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet (2006) 2.97

De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet (2012) 2.86

A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency. N Engl J Med (2015) 2.77

Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet (2012) 2.63

Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis (2012) 2.46

Delineation of the motor disorder of Lesch-Nyhan disease. Brain (2006) 2.30

Large spectrum of lissencephaly and pachygyria phenotypes resulting from de novo missense mutations in tubulin alpha 1A (TUBA1A). Hum Mutat (2007) 2.24

Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain (2010) 2.21

Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. Nat Genet (2013) 2.06

Neurological aspects of hyperinsulinism-hyperammonaemia syndrome. Dev Med Child Neurol (2008) 1.91

Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome. J Med Genet (2007) 1.89

Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort. AIDS (2003) 1.88

CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet (2008) 1.86

Mutations in the neuronal ß-tubulin subunit TUBB3 result in malformation of cortical development and neuronal migration defects. Hum Mol Genet (2010) 1.83

Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet (2009) 1.81

Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics (2008) 1.80

Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease. Hepatology (2013) 1.78

MED23 mutation links intellectual disability to dysregulation of immediate early gene expression. Science (2011) 1.74

Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis (2014) 1.73

Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis (2011) 1.63

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study. J Inherit Metab Dis (2014) 1.60

Key clinical features to identify girls with CDKL5 mutations. Brain (2008) 1.59

The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Mol Genet Metab (2013) 1.57

Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis (2011) 1.54

Cardiomyopathies in propionic aciduria are reversible after liver transplantation. J Pediatr (2010) 1.52

The ketogenic diet improves recently worsened focal epilepsy. Dev Med Child Neurol (2008) 1.48

Brain magnetic resonance imaging pattern and outcome in children with haemolytic-uraemic syndrome and neurological impairment treated with eculizumab. Dev Med Child Neurol (2013) 1.48

Mutations in the telomere capping complex in bone marrow failure and related syndromes. Haematologica (2012) 1.45

Enhanced interpretation of newborn screening results without analyte cutoff values. Genet Med (2012) 1.44

Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. Cell Rep (2012) 1.43

Respiratory chain deficiency in a female with Aicardi-Goutières syndrome. Dev Med Child Neurol (2006) 1.41

Hemiconvulsion-hemiplegia syndrome revisited: longitudinal MRI findings in 10 children. Dev Med Child Neurol (2013) 1.40

Cerebral haemorrhagic risk in children with sickle-cell disease. Dev Med Child Neurol (2014) 1.40

Transient magnetic resonance diffusion abnormalities in West syndrome: the radiological expression of non-convulsive status epilepticus? Dev Med Child Neurol (2008) 1.39

Combination of linkage mapping and microarray-expression analysis identifies NF-kappaB signaling defect as a cause of autosomal-recessive mental retardation. Am J Hum Genet (2009) 1.38

New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology (2012) 1.35

LPIN1 gene mutations: a major cause of severe rhabdomyolysis in early childhood. Hum Mutat (2010) 1.34

Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation (2003) 1.31

Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J Am Soc Nephrol (2010) 1.30

Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome. Hum Mutat (2009) 1.28

Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet A (2011) 1.26

Exome sequencing identifies MRPL3 mutation in mitochondrial cardiomyopathy. Hum Mutat (2011) 1.22

Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol (2010) 1.22

Early onset collagen VI myopathies: Genetic and clinical correlations. Ann Neurol (2010) 1.21

Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation (2009) 1.21

Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C. Orphanet J Rare Dis (2012) 1.21

Congenital hyperinsulinism. Early Hum Dev (2010) 1.21

Linking MECP2 and pain sensitivity: the example of Rett syndrome. Am J Med Genet A (2010) 1.19

Idursulfase treatment of Hunter syndrome in children younger than 6 years: results from the Hunter Outcome Survey. Genet Med (2011) 1.18

Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet A (2015) 1.17

Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis. Dev Med Child Neurol (2009) 1.15

Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders. Hum Mutat (2008) 1.14

Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression. Hum Mol Genet (2009) 1.13

Deletion of 5' sequences of the CSB gene provides insight into the pathophysiology of Cockayne syndrome. Eur J Hum Genet (2008) 1.12

An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype-phenotype study. Hum Mutat (2010) 1.11

The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia (2008) 1.11

Genotype-phenotype correlation in four 15q24 deleted patients identified by array-CGH. Am J Med Genet A (2009) 1.10

Early electro-clinical features may contribute to diagnosis of the anti-NMDA receptor encephalitis in children. Clin Neurophysiol (2013) 1.10

Clinical, cellular, and neuropathological consequences of AP1S2 mutations: further delineation of a recognizable X-linked mental retardation syndrome. Hum Mutat (2008) 1.08

Interstitial microduplication of Xp22.31: Causative of intellectual disability or benign copy number variant? Eur J Med Genet (2010) 1.08

Decreased kidney function and crystal deposition in the tubules after kidney transplant. Am J Kidney Dis (2010) 1.05

Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res (2009) 1.04

Delineation of late onset hypoventilation associated with hypothalamic dysfunction syndrome. Pediatr Res (2008) 1.04

Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP). J Inherit Metab Dis (2011) 1.04

Infantile and pediatric quinone deficiency diseases. Mitochondrion (2007) 1.03

Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: clinical score and further delineation of the TCF4 mutational spectrum. Hum Mutat (2011) 1.03

Severe gouty arthritis and mild neurologic symptoms due to F199C, a newly identified variant of the hypoxanthine guanine phosphoribosyltransferase. Arthritis Rheum (2009) 1.02

LIS1-related isolated lissencephaly: spectrum of mutations and relationships with malformation severity. Arch Neurol (2009) 1.02

Phenotypic variability in ARCA2 and identification of a core ataxic phenotype with slow progression. Orphanet J Rare Dis (2013) 1.01

A FOXG1 mutation in a boy with congenital variant of Rett syndrome. Neurogenetics (2010) 1.01

Developmental and benign movement disorders in childhood. Mov Disord (2010) 1.01

Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome. Am J Hum Genet (2004) 1.00

Expanding the spectrum of TUBA1A-related cortical dysgenesis to Polymicrogyria. Eur J Hum Genet (2012) 1.00

Clinical and molecular overlap in overgrowth syndromes. Am J Med Genet C Semin Med Genet (2005) 0.99

Spectrum of pontocerebellar hypoplasia in 13 girls and boys with CASK mutations: confirmation of a recognizable phenotype and first description of a male mosaic patient. Orphanet J Rare Dis (2012) 0.97

MRI findings in 77 children with non-syndromic autistic disorder. PLoS One (2009) 0.96

Epilepsy in Menkes disease: analysis of clinical stages. Epilepsia (2006) 0.96

Respiratory chain defects may present only with hypoglycemia. J Clin Endocrinol Metab (2005) 0.96

Bohring-Opitz (Oberklaid-Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesis. Eur J Hum Genet (2011) 0.95

Systematic search for neutropenia should be part of the first screening in patients with poikiloderma. Eur J Med Genet (2011) 0.95

Adenine phosphoribosyltransferase deficiency in children. Pediatr Nephrol (2012) 0.95

Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects. J Med Chem (2003) 0.94

Adenine phosphoribosyltransferase deficiency. Clin J Am Soc Nephrol (2012) 0.93

A missense mutation within the fork-head domain of the forkhead box G1 Gene (FOXG1) affects its nuclear localization. Hum Mutat (2010) 0.93

ARX polyalanine expansions are highly implicated in familial cases of mental retardation with infantile epilepsy and/or hand dystonia. Am J Med Genet A (2011) 0.92